NR 565 Pharmacotherapeutics for Primary Care Week 1 Quiz
Actual Exam 2026/2027: Complete Exam-Style Questions
with Detailed Rationales | 100% Verified | Pass Guaranteed –
A+ Graded
TABLE OF CONTENTS
Section 1 | Pharmacokinetics & Pharmacodynamics Principles | Q1 – Q10
Section 2 | Prescriptive Authority & Ethical Considerations | Q11 – Q20
Section 3 | Drug Interactions & Adverse Reactions | Q21 – Q30
Section 4 | Patient Education & Medication Adherence | Q31 – Q40
Section 5 | Special Populations & Safety Monitoring | Q41 – Q50
Instructions: Choose the single best answer. Pass: 80% in 90 minutes.
══════════════════════════════════════
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS PRINCIPLES Q1 – Q10
══════════════════════════════════════
Question 1 of 50
A 62-year-old patient with chronic kidney disease is prescribed a medication that is 80%
renally excreted. The prescriber reduces the dose by 50% and extends the dosing
interval from every 12 hours to every 24 hours. The patient asks why the change was
necessary. What is the primary pharmacokinetic concern the prescriber is addressing?
A. Increased volume of distribution due to reduced muscle mass
B. Accumulation of the drug caused by decreased renal clearance ✓ CORRECT
C. Enhanced hepatic metabolism secondary to compensatory pathways
D. Altered protein binding from elevated albumin levels
Correct Answer: B
Rationale: When renal clearance is impaired, drugs that depend primarily on kidney
elimination accumulate in the body and can reach toxic concentrations even at standard
,doses. Reducing the dose and extending the interval compensates for slower
elimination and helps maintain safe steady-state levels. This is a routine adjustment in
primary care for patients with reduced glomerular filtration rate.
Question 2 of 50
A nurse practitioner is teaching a patient about why some medications must be taken
on an empty stomach while others should be taken with food. The patient is taking
levothyroxine and ibuprofen. Which statement best explains the pharmacokinetic
principle behind these differing instructions?
A. Food increases gastric pH, which universally slows absorption of all medications
B. Food always enhances first-pass metabolism, requiring higher oral doses
C. Food can alter absorption rate and extent depending on the drug's physicochemical
properties ✓ CORRECT
D. Food only affects drug distribution by increasing plasma protein binding
Correct Answer: C
Rationale: Food can speed, slow, or have minimal effect on absorption depending on
whether the drug is lipophilic, acid-labile, or subject to chelation with minerals in the
meal. Levothyroxine absorption is reduced by food and calcium, while ibuprofen is
generally better tolerated with food to minimize gastric irritation despite minimal impact
on overall absorption. Understanding these distinctions helps patients follow
instructions that optimize efficacy and minimize side effects.
Question 3 of 50
A 45-year-old patient is started on a new medication that acts as a non-competitive
antagonist at a specific receptor site. During a follow-up visit, the patient asks how this
medication differs from the previous competitive antagonist that was tried. What is the
most accurate explanation?
,A. A non-competitive antagonist binds reversibly and can be overcome by increasing
agonist concentration
B. A non-competitive antagonist binds to a site other than the active receptor site or
irreversibly, reducing the maximal response regardless of agonist dose ✓ CORRECT
C. A non-competitive antagonist requires a co-agonist to produce any pharmacologic
effect
D. A non-competitive antagonist only works when the agonist is administered
intravenously
Correct Answer: B
Rationale: Non-competitive antagonists reduce the efficacy of an agonist by binding
allosterically or irreversibly to the receptor, which decreases the maximum possible
response even when agonist concentration is increased. In contrast, competitive
antagonists bind reversibly to the same active site and can be outcompeted by raising
the agonist dose. This distinction is clinically relevant when titrating medications and
assessing why a patient may not respond to dose increases.
Question 4 of 50
A patient with a history of liver cirrhosis is prescribed a drug with a narrow therapeutic
index that undergoes extensive hepatic metabolism via CYP3A4. The prescriber orders
a 30% reduction in the starting dose and plans to monitor drug levels closely. Which
pharmacokinetic principle best explains this cautious approach?
A. Cirrhosis increases hepatic blood flow, accelerating drug metabolism
B. Cirrhosis reduces first-pass metabolism and phase I biotransformation, increasing
bioavailability and half-life ✓ CORRECT
C. Cirrhosis enhances renal clearance as a compensatory mechanism
D. Cirrhosis increases plasma protein binding, reducing free drug concentration
Correct Answer: B
Rationale: Advanced liver disease impairs both first-pass extraction and hepatic enzyme
activity, leading to higher circulating drug levels and prolonged drug action after oral
administration. For drugs with narrow therapeutic indices, even modest reductions in
, hepatic clearance can precipitate toxicity, making dose reduction and therapeutic
monitoring essential. This is particularly important with CYP3A4 substrates such as
certain antiarrhythmics and immunosuppressants.
Question 5 of 50
A 38-year-old patient on a stable dose of warfarin begins experiencing unexpected
bleeding. Laboratory studies reveal an elevated INR. The patient recently started a new
over-the-counter supplement but has not changed any prescription medications or
dietary habits significantly. Which pharmacodynamic mechanism is most likely
responsible for this interaction?
A. The supplement induced CYP2C9, increasing warfarin metabolism
B. The supplement displaced warfarin from albumin, increasing free drug concentration
✓ CORRECT
C. The supplement increased vitamin K synthesis in the gut, antagonizing warfarin
D. The supplement blocked renal tubular secretion of warfarin
Correct Answer: B
Rationale: Warfarin is highly protein-bound, and substances that compete for albumin
binding sites can displace warfarin, transiently increasing the free fraction and
anticoagulant effect. Many herbal supplements and OTC products can alter protein
binding or hepatic metabolism, which is why clinicians must specifically ask about
non-prescription products during medication reviews. An elevated INR in a stable
patient should always prompt a thorough review of all substances, including
supplements.
Question 6 of 50
A nurse practitioner is comparing two antibiotics for a patient with a severe infection.
Drug X has a half-life of 4 hours and is dosed every 6 hours. Drug Y has a half-life of 24
Actual Exam 2026/2027: Complete Exam-Style Questions
with Detailed Rationales | 100% Verified | Pass Guaranteed –
A+ Graded
TABLE OF CONTENTS
Section 1 | Pharmacokinetics & Pharmacodynamics Principles | Q1 – Q10
Section 2 | Prescriptive Authority & Ethical Considerations | Q11 – Q20
Section 3 | Drug Interactions & Adverse Reactions | Q21 – Q30
Section 4 | Patient Education & Medication Adherence | Q31 – Q40
Section 5 | Special Populations & Safety Monitoring | Q41 – Q50
Instructions: Choose the single best answer. Pass: 80% in 90 minutes.
══════════════════════════════════════
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS PRINCIPLES Q1 – Q10
══════════════════════════════════════
Question 1 of 50
A 62-year-old patient with chronic kidney disease is prescribed a medication that is 80%
renally excreted. The prescriber reduces the dose by 50% and extends the dosing
interval from every 12 hours to every 24 hours. The patient asks why the change was
necessary. What is the primary pharmacokinetic concern the prescriber is addressing?
A. Increased volume of distribution due to reduced muscle mass
B. Accumulation of the drug caused by decreased renal clearance ✓ CORRECT
C. Enhanced hepatic metabolism secondary to compensatory pathways
D. Altered protein binding from elevated albumin levels
Correct Answer: B
Rationale: When renal clearance is impaired, drugs that depend primarily on kidney
elimination accumulate in the body and can reach toxic concentrations even at standard
,doses. Reducing the dose and extending the interval compensates for slower
elimination and helps maintain safe steady-state levels. This is a routine adjustment in
primary care for patients with reduced glomerular filtration rate.
Question 2 of 50
A nurse practitioner is teaching a patient about why some medications must be taken
on an empty stomach while others should be taken with food. The patient is taking
levothyroxine and ibuprofen. Which statement best explains the pharmacokinetic
principle behind these differing instructions?
A. Food increases gastric pH, which universally slows absorption of all medications
B. Food always enhances first-pass metabolism, requiring higher oral doses
C. Food can alter absorption rate and extent depending on the drug's physicochemical
properties ✓ CORRECT
D. Food only affects drug distribution by increasing plasma protein binding
Correct Answer: C
Rationale: Food can speed, slow, or have minimal effect on absorption depending on
whether the drug is lipophilic, acid-labile, or subject to chelation with minerals in the
meal. Levothyroxine absorption is reduced by food and calcium, while ibuprofen is
generally better tolerated with food to minimize gastric irritation despite minimal impact
on overall absorption. Understanding these distinctions helps patients follow
instructions that optimize efficacy and minimize side effects.
Question 3 of 50
A 45-year-old patient is started on a new medication that acts as a non-competitive
antagonist at a specific receptor site. During a follow-up visit, the patient asks how this
medication differs from the previous competitive antagonist that was tried. What is the
most accurate explanation?
,A. A non-competitive antagonist binds reversibly and can be overcome by increasing
agonist concentration
B. A non-competitive antagonist binds to a site other than the active receptor site or
irreversibly, reducing the maximal response regardless of agonist dose ✓ CORRECT
C. A non-competitive antagonist requires a co-agonist to produce any pharmacologic
effect
D. A non-competitive antagonist only works when the agonist is administered
intravenously
Correct Answer: B
Rationale: Non-competitive antagonists reduce the efficacy of an agonist by binding
allosterically or irreversibly to the receptor, which decreases the maximum possible
response even when agonist concentration is increased. In contrast, competitive
antagonists bind reversibly to the same active site and can be outcompeted by raising
the agonist dose. This distinction is clinically relevant when titrating medications and
assessing why a patient may not respond to dose increases.
Question 4 of 50
A patient with a history of liver cirrhosis is prescribed a drug with a narrow therapeutic
index that undergoes extensive hepatic metabolism via CYP3A4. The prescriber orders
a 30% reduction in the starting dose and plans to monitor drug levels closely. Which
pharmacokinetic principle best explains this cautious approach?
A. Cirrhosis increases hepatic blood flow, accelerating drug metabolism
B. Cirrhosis reduces first-pass metabolism and phase I biotransformation, increasing
bioavailability and half-life ✓ CORRECT
C. Cirrhosis enhances renal clearance as a compensatory mechanism
D. Cirrhosis increases plasma protein binding, reducing free drug concentration
Correct Answer: B
Rationale: Advanced liver disease impairs both first-pass extraction and hepatic enzyme
activity, leading to higher circulating drug levels and prolonged drug action after oral
administration. For drugs with narrow therapeutic indices, even modest reductions in
, hepatic clearance can precipitate toxicity, making dose reduction and therapeutic
monitoring essential. This is particularly important with CYP3A4 substrates such as
certain antiarrhythmics and immunosuppressants.
Question 5 of 50
A 38-year-old patient on a stable dose of warfarin begins experiencing unexpected
bleeding. Laboratory studies reveal an elevated INR. The patient recently started a new
over-the-counter supplement but has not changed any prescription medications or
dietary habits significantly. Which pharmacodynamic mechanism is most likely
responsible for this interaction?
A. The supplement induced CYP2C9, increasing warfarin metabolism
B. The supplement displaced warfarin from albumin, increasing free drug concentration
✓ CORRECT
C. The supplement increased vitamin K synthesis in the gut, antagonizing warfarin
D. The supplement blocked renal tubular secretion of warfarin
Correct Answer: B
Rationale: Warfarin is highly protein-bound, and substances that compete for albumin
binding sites can displace warfarin, transiently increasing the free fraction and
anticoagulant effect. Many herbal supplements and OTC products can alter protein
binding or hepatic metabolism, which is why clinicians must specifically ask about
non-prescription products during medication reviews. An elevated INR in a stable
patient should always prompt a thorough review of all substances, including
supplements.
Question 6 of 50
A nurse practitioner is comparing two antibiotics for a patient with a severe infection.
Drug X has a half-life of 4 hours and is dosed every 6 hours. Drug Y has a half-life of 24
